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Abstract
OBJECTIVE: To evaluate the efficacy and safety of
Traditional Chinese Medicine (TCM) herbs for toni-
fying Qi and kidney, and replenishing spleen on in-
termittent asthma in children aged 2 and 5 years.
METHODS: A randomized, single-blind, placebo
controlled trial was conducted. Children with inter-
mittent asthma were enrolled and their baseline
conditions were measured using a questionnaire. A
total of 60 participants, aged 2 to 5, were random-
ized into either the treatment group (n = 40) or the
placebo group (n = 20). The treatment group was
treated with granules of TCM herbs for tonifying Qi
and kidney, and replenishing spleen, and the place-
bo group was given placebo granules for 3 months.
The number of asthma attacks was counted and
TCM syndrome scores were measured at 1, 2, 3, 6, 9,
and 12 months. The airway resistance and levels of
eosinophil cationic protein for the two groups were
observed before and after 3 months. The results
were statistically analyzed.
RESULTS: Compared with the placebo group, the
number of asthma attacks significantly decreased
in the treatment group (P < 0.05). For the treatment
group, the TCM syndrome scores decreased after 1
and 2 months; there was also a significant differ-
ence in scores between the two groups (P < 0.05).
The difference remained after the medicine was
stopped for 9 months (P < 0.05). After the 3-month
treatment, compared with the placebo group, the
airway resistance decreased in the treatment group
(P < 0.05). No adverse events were reported in the
treatment group.
CONCLUSION: The TCM herbs for tonifying Qi and
kidney, and replenishing spleen reduced the num-
ber of intermittent asthma attacks, decreased the
TCM syndrome scores, and reduced the airway re-
sistance in the children aged 2 to 5.
© 2016 JTCM.
Key words: Asthma; Child, preschool; Medicine,
Chinese traditional; Reinforcing Qi and kidney;
Strengthening spleen
INTRODUCTION
Asthma is the most common chronic respiratory dis-
ease in children.1 In recent years, the prevalence of asth-
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ma in children was on the rise all over the world.2 The
total incidence of childhood asthma in the cities of
China was 3.02% and increased by 52.8% compared
with 10 years ago.3 In domestic and foreign research
studies, most patients with asthma were found to have
onset of disease before the age of 5, especially among
1-3 year olds, and most of them were in an intermit-
tent state.4 It is unnecessary for such children to take
long-term control medicine and on-demand inhaled β
2-agonists were enough for them during asthma at-
tacks as specified by the Global Initiative for Asthma
(GINA).5 The parents also generally ignored and did
not take any interventions because of their children's
mild disease. Research suggests that intermittent asth-
ma in children will be aggravated without intervention
or if the intervention taken is insufficient. In Tradition-
al Chinese Medicine (TCM) theory, it is believed that
the essence of asthma is a result of a deficiency of lung,
spleen, and kidney. It is believed that medicine for
strengthening the body's resistance should be taken
when patient is in a relief stage from asthma. Over the
years, the main therapy in TCM was to tonify the
lung, invigorate the spleen, and reinforce the kidney
for patients with asthma during remission. Previous re-
search showed that the therapy could prevent asthma
from getting worse.6 In the present trial, TCM herbs
for tonifying Qi and kidney, and replenishing the
spleen were given to children 2 to 5 years of age with
intermittent asthma using a randomized, single-blind,
and placebo controlled trial design to evaluate the safe-
ty of the TCM herbal granule.
METHODS
Study design
The trial used a parallel group, randomized, sin-
gle-blind (the children and their guardians did not
know, the experimenters knew), and placebo con-
trolled clinical trial.
This research has been investigated and approved by
the ethics committee of the General Hospital of the
Air Force Chinese people's liberation army. The chil-
dren's parents or guardian understood the purpose of
this study and signed the information consent forms.
The research project was reviewed and approved by the
ethics committee of the General Hospital of the Air
Force Chinese People's Liberation Army. The chil-
dren's parents or guardians understood the purpose of
the study and signed the informed consent forms. En-
rolled patients were randomly assigned to the treat-
ment group or the placebo group using a ratio of 2∶1.
The children and their guardians were blinded to treat-
ment group assignment. All the children in the trial
were randomized (using computer randomization) into
a TCM herbal granule group (treatment group) and a
placebo group, and were given TCM herbal granule or
placebo accordingly. Before treatment (T0), baseline
questionnaires for all enrolled children were completed
by the experimenters. Children were tested for levels of
eosinophil cationic protein (ECP) and airway resis-
tance. The TCM syndrome scores and number of asth-
ma attacks were recorded before treatment (T0). The
participants were followed up once a month for 3
months (1 month [T1], 2 months [T2], 3 months
[T3]), and followed up once every 3 months following
the 3-month intervention period (including 6 months
[T4], 9 months [T5], and 12 months [T6]). The num-
ber of asthma attacks and the TCM syndrome scores
were recorded by the experimenters. At the T3 point,
the level of airway resistance and ECP was tested again.
Sample size calculation
Reviewing the related literature,7,8 with no more than
5% probability of a type I error and not more than
10% for a type II error are required (i.e., α = 0.05, β =
0.10), the sample size was calculated based on the esti-
mation formula for two sample means comparison, in
which 20 cases were included in one group. Taking
ethical factors into consideration, the sample size in
the treatment group was two times that of the placebo
group. The rates of loss to follow-up and dropout did
not exceed 20%.
Diagnostic criteria
The diagnosis of bronchial asthma in Western Medi-
cine was consistent with the "Diagnosis and Preven-
tion Guideline for Bronchial Asthma in Children
(2008 Edition)" by the Pediatric Respiratory Study
Group of the Chinese Medical Association.7 The "Cri-
teria of diagnostic efficacy of TCM Syndrome" by the
State Administration of Traditional Chinese Medicine
was referenced as a TCM diagnosis and differentiation
standard.9
Inclusion criteria
Children with intermittent asthma and remission ac-
cording to the Western Medicine and TCM syndrome
differentiation criteria, who were 2 to 5 years of age,
with no complications except asthma, whose parents or
guardians of children provided informed consent, and
whose bronchodilators, hormone therapies, and other
medications had not been taken within 1 month were
included in the study.
Exclusion criteria
Patients were excluded from the study if one of the fol-
lowing occurred: (a) in addition to asthma, the chil-
dren were ill with other serious diseases; (b) other le-
sions could decrease the possibility or increase the
complexity of entering into the study; (c) the pa-
tients who did not conform to the inclusion criteria,
or not take the TCM herbal granules and placebo as
specified in the study design; (d) participating in oth-
er clinical trials; or (e) known allergies to the ingredi-
ents of the medicine.
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Intervention
Those in the treatment group received TCM herbal
granules for tonifying Qi and kidney, and replenishing
the spleen: Huangqi (Radix Astragali Mongolici) 10 g,
Yuzhu (Rhizoma Polygonati odorati) 10 g, Nǚzhenzi
(Fructus Ligustri Lucidi) 10 g, Buguzhi (Fructus Psorale-
ae) 10 g, Taizishen (Radix Pseudostellariae) 3 g, Wu-
weizi (Fructus Schisandrae Chinensis) 3 g, Dazao (Fruc-
tus Jujubae) 10 g, Muli (Concha Ostreae) 10 g, and
Haipiaoxiao (Endoconcha Sepiellae) 10 g. Participants <
3 years old consumed 1/4 of the dose twice daily with
25 mL of boiling water. Those 3-5 years old consumed
1/3 of the dose twice daily with 30 mL of boiling wa-
ter. Treatment continued for 3 months. Participants in
the placebo group were given placebo granules, which
had the same taste and appearance as that of the TCM
herbal granules, but were free of medicine. Directions
and the treatment course were the same as those of the
treatment group. The TCM herbal granules and place-
bo granules were produced by San Jiu Shenzhen mod-
ern Chinese Medicine Co., Ltd., (Shenzhen, China),
were stored at room temperature, and were provided
by department of pharmacy at the General Hospital of
the Air Force Chinese people's liberation army. Except
for the experimental medications as specified, anti-aller-
gy, bronchodilators, and other medications were not al-
lowed to be given to the patients during the study peri-
od. Budesonide suspension and Ventolin inhalation
were given when the patients experienced acute asth-
ma; the anti-infective therapy was used as necessary.
Outcome measures
The condition baseline questionnaire for the children
with intermittent asthma included demographic infor-
mation, personal and family history of allergies and dis-
eases (including eczema and allergic rhinitis), and num-
ber of asthma attacks/year. Serum levels of immuno-
globulin IgA, IgG, IgM, and anaphylactogen (serolo-
gy) were determined and recorded by the experiment-
ers. The experimenters recorded the number of asthma
attacks before and after treatment (T0-T6) of the two
groups and the TCM syndrome scores (Table 1). The ad-
verse effects were recorded (vomiting, rash, constipation).
The level of airway resistance (Rint value) before and
after treatment (at T0 and T3) of the two groups was
determined by a technical professional at the lung func-
tion laboratory using Microloop pulmonary function
instrument (model: MTCROLAB) (Micro Medical
Ltd., Kent John green, England) with a MicroRint
loading sensor.
Blood samples were obtained at T0 and T3 in outpa-
tient pediatrics. The levels of ECP were tested using
the radio immunoassay (RIA) room at the General
Hospital of the Air Force Chinese people's liberation
army. Enzyme-linked immunosorbent assays (ELISA)
were used. The test kits were produced by Pharmacia
Company in Sweden.
Safety
Symptoms of adverse effects during the trial were re-
corded following routine examination of the blood,
urine and stool, kidney function, liver function, electro-
cardiogram, and X-ray films of the chest in the patients
in the treatment group. For safety purposes, the num-
ber cases of examination should not be less than 1/3 of
the total cases.
Data analysis
Data were analyzed using SPSS 17.0 (Boyi Consultant
Information Technology Company, Beijing, China).
The measurement data were expressed in mean ± stan-
dard deviation ( xˉ ± s) and the count data represented
by n.T-tests and χ2tests were performed for the measure-
ment and count data, respectively. The adverse reac-
tions of the medicine were expressed using descriptive
analysis.P<0.05was considered statistically significant
RESULTS
Participants and grouping
The participants in the sample (n = 60) were aged 2 to
5 years with intermittent asthma (with no asthma
Syndrome
Cough
Phlegm
Sweat
Diet
Complexion
Spirit
Tongue proper
Tongue coat
0
No
No
No obvious
sweating
Normal
Normal
Normal
Normal
Normal
2
Occasional cough
Occasional phlegm sound in the throat
Obvious sweating, especially after activi-
ty or sleep
The intake of food is less than 2/3 that
of their peers. Or sometimes with ab-
dominal pain or nausea occasionally.
Pale complexion
Be easy to tired after activity
Tongue short or red; white and greasy
Moss yellow or geographica
4
Occasional cough, slightly worse when stimulated.
Sputum came and went, which can be expectorated
occasionally.
They sweat terribly after slight activity, or profuse
sweating after sleep and clothing was soaked.
The intake of food is less than half that of their peers, or
sometimes they have abdominal pain or nausea
occasionally.
Sallow and pale.
Lethargy
-
-
Note: TCM: Traditional Chinese Medicine.
Table 1 Standard of the TCM syndrome scores with general condition
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acute attacks) and were recruited from the outpatient
pediatrics clinic of the General Hospital of the Air
Force from October 2009 to February 2013 (Figure 1).
According to the experimental design, all children were
randomly divided into either the treatment group (n =
40) or the placebo group (n = 20). The treatment
group consisted of 30 males and 10 females,（3.6 ±
0.9）years old, with an average disease course of（1.6 ±
0.9） years. The placebo group was made up of 17
males and 3 females,（3.4 ± 0.9）years old, with an av-
erage disease course of（1.8 ± 1.0）years. There were
no significant differences between the two groups in
terms of age, gender (Female / Male), height, weight,
average disease course, personal and family history of
allergies and diseases, the number of asthma attacks /
year before treatment, TCM syndrome scores, levels of
airway resistance, serum total IgE levels, or serum lev-
els of IgA, IgG, IgM, and ECP (Table 2). In the pres-
ent study, 55/60 patients completed the treatment, in-
cluding 38 cases from the treatment group and 17 cas-
es from the placebo group. The dropout and loss to fol-
low-up rate were 5% and 15% , respectively, in the
treatment group and placebo group.
Outcome measures
Compared with the preoperative data before entering
the groups (Table 3), the number of asthma attacks sig-
nificantly decreased in the treatment group (P < 0.05);
however, there was no significant difference in the pla-
cebo group. The TCM syndrome scores in the treat-
ment group at T1 improved and there was no obvious
difference compared with the placebo group. The
scores at T2, T3, T4, and T5 significantly improved
compared with the placebo group, or before the treat-
ment, and the difference was statistically significant
(P < 0.05).
Airway resistance before and after treatment
After the treatment, airway resistance in the treatment
group at T3 (0.82 ± 0.28, P < 0.05) was significantly
different compared with preoperative data. As for the
placebo group (0.97 ± 0.40 vs 1.00 ± 0.46, P > 0.05)
at T3, there was no significant difference compared
with preoperative data. The difference at T3 was statis-
tically significant between the two groups (P < 0.05)
(Table 3).
ECP before and after treatment
The levels of ECP had no significant change between
the two groups before and after treatment (P > 0.05)
(Table 3).
Adverse reaction
During the clinical observation, no adverse events were
noted in the two groups. A sample of 18 cases were ran-
domly selected from the treatment group and tested
for safety. Abnormal events were not found.
DISCUSSION
The present study demonstrated that the number of
asthma attacks would not be reduced if no therapeutic
interventions were given to those children with intermit-
tent asthma, and may even worsen. However, the num-
ber of asthma attacks significantly decreased with the
treatment of the TCM herbal granules; the airway resis-
tance decreased and theTCM syndrome scores improved
significantly. The results support the idea that early in-
tervention should be given to children with intermit-
tent asthma so as to stop progression of the disease.
Traditional Chinese Medicine consider that asthma is
associated with delicate lung, asthenic susceptibility of
the spleen and kidney in childhood, with the diseased
positions mainly in the lung, spleen, and kidney. The
principle of treatment in ancient and modern tradi-
tions, which is used to treat asthma during remission,
is mainly strengthening of the vital energy to eliminate
pathogenic factors. Therefore, strengthening the resis-
tance of the body is an important measure in the treat-
ment of asthma. On syndrome differentiation and
treatment, doctors lay particular stress on the lung,
spleen, or kidney. However, it is still a main therapy to
replenish and restore the pulmonary system, invigorate
the spleen, and reinforce the kidney on the whole. This
prescription, which is made up of TCM herbs for toni-
fying Qi and kidney, and replenishing the spleen, are
lessons drawn from our clinical experience in the treat-
ment of asthma, in which Huangqi (Radix Astragali
Mongolici) and Taizishen (Radix Pseudostellariae) for in-
vigorating Qi and strengthening the spleen; Wuweizi
(Fructus Schisandrae Chinensis) for vital energy and rein-
forcement of the kidney; Buguzhi (Fructus Psoraleae)
for warming the kidney, strengthening the spleen, and
promoting inspiration to relieve asthma; Yuzhu (Rhi-
zoma Polygonati odorati) for nourishing Yin and mois-
turizing the lung; Nǚzhenzi (Fructus Ligustri Lucidi),
Haipiaoxiao (Endoconcha Sepiellae), and Muli (Concha
Ostreae) for tonifying kidney-Qi; and Dazao (Fructus
Jujubae) for tonifying middle-Jiao and vital energy.
This prescription has the effect of benefiting vital ener-
gy, strengthening the spleen, and reinforcing the kid-
ney. According to modern pharmacology, Huangqi (Ra-
dix Astragali Mongolici) has antioxidant effects,10 im-
Completed the study (n=17)
The loss and dropout (poor
drug concordance n = 1; par-
ents considered that the medi-
cine failed to take effectn =2)
Sixty children patients enrolled into the study,
aged 2 to 5 with intermittent asthma, random-
ized grouping (with non-asthma acute attack)
Treatment group (n = 40)
Completed the study (n = 38)
The loss and dropout (poor
drug concordance, n = 2)
Placebo group (n = 20)
Figure 1 Flow diagram of the trial
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mune regulation properties, anti-inflammatory proper-
ties, and other pharmacological activities and it is quite
effective in the treatment of asthma.11 The study by Cai
et al 12 found that astragaloside could inhibit the infil-
tration of eosinophils in mice with allergic asthma.
Asthmatic airway inflammation of the mice was also re-
duced. Yu et al 13 found that astragalus polysaccharides
might play a role in the improvement of airway remod-
eling and decreased airway hyperresponsiveness. The
compound was helpful in treating asthma and prevent-
ing against asthma attacks. The ethanol extracts from
Wuweizi could reduce airway hyperresponsiveness by
raising the antioxidant activity and decreasing the infil-
tration of eosinophils in the airway.14 The ethyl acetate
extract of Taizishen showed an obvious effect on reliev-
ing cough. It decreased airway inflammation by regulat-
ing IL-8, colony-stimulating factor, TNF-α, endothe-
lin 1, and other cytokine levels.15 Total coumarins of
Psoraleae had obvious antagonism against asthma, and
notably prolonged the latency of allergic asthma and
histamine asthma.16,17 The Muli (Concha Ostreae), Yu-
zhu (Rhizoma Polygonati odorati), and Nǚzhenzi (Fruc-
Item
Age (years)
Gender (M/F)
Height (cm)
History of asthma (years)
History of personal allergies (Y/N)
Family history of anaphylactic
disease (Y/N)
Number of asthma attacks (years)
TCM syndrome score
Serum total IgE levels (KU/L)
Serum immunoglobulin levels (g/L)
ECP (μg/L)
Airway resistance (kpa/L/S)
Treatment group
(n = 40)
IgA
IgG
IgM
3.6±0.9
30/10
18.1±4.1
1.6±0.9
30/10
25/15
3.8±1.7
11.0±2.7
120.9±165.5
1.1±1.4
8.6±2.5
1.3±0.4
15.9±13.1
1.0±0.4
Placebo group
(n = 20)
3.4±0.9
17/3
16.6±3.1
1.8±1.0
13/7
11/9
3.9±2.1
9.5±3.1
116.6±179.1
0.8±0.5
8.6±3.1
1.3±0.4
23.2±35.4
1.0±0.5
Notes: treatment group: patients were given the TCM herbal granules for tonifying Qi and kidney, and replenishing the spleen. Placebo
group: patients were given placebo granules, which had the same taste and appearance as TCM herbal granules, but were free of medicine.
y: year; M: male; F: female; Y: yes; N: no; TCM: Traditional Chinese Medicine; ECP: eosinophil cationic protein.
Table 2 Comparison of baseline characteristics of the patients between two groups at T0 ( xˉ ± s)
Item
Number of asthma attacks (years)
TCM syndrome scores
Airway resistance (kpa/L/S)
ECP (μg/L)
T1
T2
T3
T4
T5
T6
T3
T3
Treatment group
(n = 38)
2.18±1.57ac
7.74±2.91a
6.26±2.80ac
4.53±3.44ac
4.11±2.90ac
3.58±2.72ac
3.37±1.55ac
0.82±0.28ac
19.27±35.27b
Placebo group
(n = 17)
4.94±4.85b
8.71±3.16
9.41±4.23b
9.29±3.60b
9.29±4.00b
8.35±4.14b
8.24±2.91b
0.97±0.40b
19.52±30.32b
Notes: treatment group: patients were given the TCM herbal granules for tonifying and kidney, and replenishing the spleen. Placebo
group: patients were given the placebo granules, which had the same taste and appearance as the TCM herbal granules, but were free of
medicine. TCM: Traditional Chinese Medicine; ECP: eosinophil cationic protein; a: vs. baseline of before treatment, P < 0.05; b: vs base-
line of before treatment, P > 0.05; c: vs between the two group, P < 0.05; T1: 1 month; T2: 2 months; T3: 3 months; T4: 6 months; T5: 9
months; T6, 6 months.
Table 3 Comparison of the number of asthma attacks, TCM syndrome scores, airway resistance, and ECP at different time points
( xˉ ± s)
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tus Ligustri Lucidi) have immune regulatory proper-
ties.18-20 The combination of medicines can supplement
Qi, strengthen the spleen, reinforce kidney, and de-
crease asthma attacks.
TCM syndrome scores decreased after 1 month; the
scores significantly decreased after 2 months in the
treatment group. Meanwhile, there was a significant
difference between the two groups and the difference
normally remained after stopping the medicine for 9
months. It was found that the effect was slower, but
the maintenance of benefits was maintained for a long
time. It would not be effective if the TCM herbal gran-
ules were taken only for a short time. The children
with intermittent asthma are in poor compliance after
prolonged use of medications and the family is bur-
dened financially because of big medical bills. There-
fore, it is suggested that the appropriate time for taking
the TCM herbal granules is 3 months so as to improve
general health of the children with asthma and obtain
maximum benefits.
In this trial, adverse reactions were not found among
patients in the treatment group, and there was no inter-
ruption of treatment as a result of medicine intoler-
ance. Thus, the TCM herbs for tonifying Qi and kid-
ney, and replenishing the spleen not only have curative
effects, but also simple methods of medication adminis-
tration and good compliance among children with in-
termittent asthma.
The imperfections and limitations in the research are
as follows. The sample size was relatively small and
easy to generate a slight bias. The observation time of
this trial was only 1 year, so there was no further re-
search on airway resistance and ECP values of patients
after 1 year. Additionally, there were no follow-up vis-
its along with the growth and change of the disease
within 2 to 3 years.
The trial results show that interventions are necessary
for children with intermittent asthma. It is thought
to be too conservative that long-time interventions
are unnecessary for the children with asthma and
quite a few of the children would seriously worsen
with a lack of interventions. The therapeutic sched-
ule for children with intermittent asthma remains to
be perfected in the GINA. The present research
study may provide valuable evidence for updating the
guideline.
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